Caas Capital Management LP Vaccitech PLC Transaction History

Caas Capital Management LP

  • $1.31 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$8.98 - $15.55 $92,053 - $159,403
-10,251 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$14.0 - $16.5 $556,486 - $655,858
-39,749 Reduced 79.5%
10,251 $161,000
Q2 2021

Aug 16, 2021
BUY
$13.03 - $17.0 $651,500 - $850,000
50,000 New
50,000 $839,000

Others Institutions Holding VACC

# of Institutions
17
Shares Held
14.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vaccitech plc

VACC Quotes by TradingView
  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email